LifeScience

C-Ray Therapeutics Activates FDA DMF For Copper 64 Radiolabelling To Enable Global IND And NDA Submissions

DMF No. 43568 is now active and available for reference in global IND and NDA submissions C-Ray Therapeutics (Chengdu) Co., Ltd., announced that its Type ...

 April 30, 2026 | News

Becton Dickinson and Company And Suttons Creek Partner To Streamline Combination Product Development

The collaboration brings together consulting, device agnostic testing, and drug delivery expertise to help pharmaceutical and biotech companies reduce risk...

 April 29, 2026 | News

Xcovery Partners With EVERSANA To Expand U.S. Launch Of ENSACOVE For ALK Positive Lung Cancer

 Xcovery Holdings, Inc., (Xcovery) an evidence-based, innovation-driven pharmaceutical company, announced an agreement with EVERSANA®, a leading p...

 April 29, 2026 | News

Thermo Fisher Scientific To Divest Microbiology Business To Astorg In $1.075 Billion Deal

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,  announced that it has signed a definitive agreement to sell its micro...

 April 28, 2026 | News

Leinco Technologies And CellCarta Partner To Advance Proteomics In Immuno Oncology

Leinco Technologies, a leader in antibody and protein development, and CellCarta, a global provider of precision medicine laboratory services, are ple...

 April 22, 2026 | News

Datasea Delivers AI Multimodal Projects Worth RMB 6.9 Million To Accelerate High Margin Shift

Completed Projects Further Support the Company's Transition Toward High-Margin, Solution-Driven Revenue and Strengthen Customer Stickiness Across AI Multim...

 April 22, 2026 | News

SynSmart And Amporin Partner To Advance Small Molecule Therapies For Degenerative Diseases

SynSmart Rasayan Research Private Limited and Amporin Pharmaceuticals AG  announced a collaboration to develop breakthrough small molecule therapeutic...

 April 22, 2026 | News

Hexagon AB To Acquire Waygate Technologies To Expand Non Destructive Testing Capabilities

Acquisition establishes Hexagon as a leading global provider of non-destructive testing (NDT) solutions, extending precision measurement from the surface...

 April 20, 2026 | News

Perceptive Discovery Partners MH3D To Launch α Sight Imaging For Alpha Radiopharmaceuticals

Perceptive Discovery announced a strategic partnership with MH3D alongside the launch of α-Sight™, a new preclinical imaging offering enabling ...

 April 17, 2026 | News

Mabwell Secures NMPA IND Acceptance For First In Class LILRB4 CD3 Bispecific Antibod

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the National Medical Products Ad...

 April 17, 2026 | News

BioMed X Expands Into France With AI Driven Bispecific Antibody Research Team

BioMed X, a leading innovation hub for pharma, has officially launched its first research team at BioMed X France, marking the establishment of its pr...

 April 17, 2026 | News

DualityBio Secures NMPA Review For Trastuzumab Pamirtecan In HER2 Positive Breast Cancer

DualityBio announced that the Biologics License Application (BLA) for the investigational antibody-drug conjugate ("ADC") trastuzumab pamirtecan ("T-Pam", ...

 April 14, 2026 | News

GenScript Biotech Corporation And Mimulus Corp Collaborate To Industrialise DNA Based Data Storage

The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. GenScript Biotech Corp...

 April 14, 2026 | News

Vivatides Secures USD 54 Million Series A To Advance Next Generation RNA Therapeutics Beyond Liver Targets

Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies Vivatides Therapeutics, a global biotechnology ...

 April 13, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close